4
Changes in Ownership
Immunome Inc. Filed Acc 0001831215-26-000005
CHIEF BUSINESS OFFICER sold 90,616 shares at $25.09 ($2,273,555)
- CHIEF BUSINESS OFFICER acquired 90,616 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Horn Kinney · CHIEF BUSINESS OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,366 | $12.92 | $650,729 | 50,366 | D |
| 2026-08-04 | Exercise or conversion : show line 2 in the form 10b5-1 | +40,250 | $10.60 | $426,650 | 90,616 | D |
| 2026-08-04 | Sale : show line 3 in the form 10b5-1 | −90,616 | $25.09 | $2,273,555 | 0 | D |
| Open-market sales · 90,616 sh · avg $25.09 · $2,273,555 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-04 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) | −50,366 | 78,542 | D |
| 2026-08-04 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −40,250 | 120,750 | D |
Loading xslF345X06/form4-08062026_100833.xml…